Literature DB >> 25505306

A rigid and bioabsorbable material for anterior chest wall reconstruction in a canine model.

Masatsugu Hamaji1, Fumitsugu Kojima2, Sho Koyasu3, Tomomi Nobashi3, Tatsuaki Tsuruyama4, Hiroshi Date5, Tatsuo Nakamura6.   

Abstract

OBJECTIVES: The optimal material for anterior chest wall reconstruction following chest wall resection remains controversial. The aim of this experimental study was to evaluate short-term, morphological and histological outcomes of anterior chest wall reconstruction with a rigid and bioabsorbable material in a canine model.
METHODS: Twenty adult beagle dogs underwent anterior chest wall resection. In the experimental group (n = 10), the anterior chest wall was reconstructed with a rigid and bioabsorbable material composed of poly-L-lactide acid matrix (60 wt%) and uncalcined and unsintered hydroxyapatite particles (40 wt%), whereas in the control group it was (n = 10) reconstructed with dual polypropylene mesh sheets. Short-term complication rates were compared with a χ(2) test. Postoperative sternal deviations were evaluated with sternal alignment angles using computed tomography and multiplanar reconstruction and were compared with Mann-Whitney U-test immediately after reconstruction, and at 1, 3, 6, 9 and 12 months postoperatively. Histological findings of the regenerated chest wall tissue were obtained after staining with haematoxylin and eosin and Elastica van Gieson (EVG) and compared at 3, 6, 9 and 12 months.
RESULTS: There was not a significant difference in the short-term postoperative complication rate (P = 0.53) and the complication rate was 20% (wound infection, n = 1 and lethal mediastinitis, n = 1) in the control group and 10% (wound infection, n = 1) in the experimental group. The postoperative sternal deviation was significantly less remarkable at 1 month (123.3 ± 32.2° vs 159.4 ± 19.7°, P = 0.027), 3 months (109.8 ± 34.7° vs 150.9 ± 34.2°, P = 0.039) and 12 months (61 ± 15.6° vs 170.3 ± 6.6°, P = 0.046) in the experimental group than in the control group, whereas no significant difference was noted immediately after reconstruction (165.7 ± 6.4° vs 168.4 ± 9.1°, P = 0.50). Histological findings showed dense connective tissue in the regenerated chest wall in both groups and showed chondroblasts in the regenerated chest wall tissue at 3 and 6 months only in the experimental group.
CONCLUSIONS: Our results suggest that anterior chest wall reconstruction with a rigid and bioabsorbable material is feasible and may be a valuable alternative to reconstruction with a non-rigid and non-absorbable material.
© The Author 2014. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Chest wall; Prosthesis; Sternum

Mesh:

Substances:

Year:  2014        PMID: 25505306     DOI: 10.1093/icvts/ivu416

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  3 in total

1.  Sternal semi-closure using a bioresorbable osteosynthesis device: a new method for delayed sternal closure.

Authors:  Yuki Tanaka; Takashi Miyamoto; Yuji Naito; Shuichi Yoshitake; Akihiro Sasahara; Kagami Miyaji
Journal:  Surg Today       Date:  2018-03-16       Impact factor: 2.549

2.  Experimental study of ASCs combined with POC-PLA patch for the reconstruction of full-thickness chest wall defects.

Authors:  Yuanzheng Zhang; Shuo Fang; Jiezhi Dai; Lei Zhu; Hao Fan; Weiya Tang; Yongjie Fan; Haiying Dai; Peipei Zhang; Ying Wang; Xin Xing; Chao Yang
Journal:  PLoS One       Date:  2017-08-11       Impact factor: 3.240

Review 3.  Expert consensus on resection of chest wall tumors and chest wall reconstruction.

Authors:  Lei Wang; Xiaolong Yan; Jinbo Zhao; Chang Chen; Chun Chen; Jun Chen; Ke-Neng Chen; Tiesheng Cao; Ming-Wu Chen; Hongbin Duan; Junqiang Fan; Junke Fu; Shugeng Gao; Hui Guo; Shiping Guo; Wei Guo; Yongtao Han; Ge-Ning Jiang; Hongjing Jiang; Wen-Jie Jiao; Mingqiang Kang; Xuefeng Leng; He-Cheng Li; Jing Li; Jian Li; Shao-Min Li; Shuben Li; Zhigang Li; Zhongcheng Li; Chaoyang Liang; Nai-Quan Mao; Hong Mei; Daqiang Sun; Dong Wang; Luming Wang; Qun Wang; Shumin Wang; Tianhu Wang; Lunxu Liu; Gaoming Xiao; Shidong Xu; Jinliang Yang; Ting Ye; Guangjian Zhang; Linyou Zhang; Guofang Zhao; Jun Zhao; Wen-Zhao Zhong; Yuming Zhu; Karel W E Hulsewé; Yvonne L J Vissers; Erik R de Loos; Jin Yong Jeong; Giuseppe Marulli; Alberto Sandri; Zsolt Sziklavari; Jacopo Vannucci; Luca Ampollini; Yuichiro Ueda; Chaozong Liu; Andrea Bille; Masatsugu Hamaji; Beatrice Aramini; Ilhan Inci; Cecilia Pompili; Hans Van Veer; Alfonso Fiorelli; Ricciardi Sara; Inderpal S Sarkaria; Fabio Davoli; Hiroaki Kuroda; Servet Bölükbas; Xiao-Fei Li; Lijun Huang; Tao Jiang
Journal:  Transl Lung Cancer Res       Date:  2021-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.